New Oxford Trial to Gather More Data on Benefits, Side Effects of anti-Covid Pill Molnupiravir: Expert

ICMR chief Dr Balram Bhargava on January 5 raised doubts on the safety profile of the oral drug and restricted it from becoming part of the country's Covid-19 treatment protocol.

from Top India News- News18.com https://ift.tt/3I15PXv
ICMR chief Dr Balram Bhargava on January 5 raised doubts on the safety profile of the oral drug and restricted it from becoming part of the country's Covid-19 treatment protocol.